Sight Sciences Inc. Common Stock (SGHT)
Stock · NASDAQ · Health Care
$8.3as of 10/16/2026
Price chart
Active signals
SGHT Signal Track Record
How signals performed across all stocks →What SGHT's price did in the 20 trading sessions after each past signal, compared with any 20-session window over the same period.
| Signal | Times | Median 20-session return | Higher after 20 sessions | Last signal |
|---|---|---|---|---|
| Volume Spike | 40 | -3.3% | 48% | October 5, 2026 |
| Bollinger Band Breakout | 23 | -2.3% | 48% | September 25, 2026 |
| Bollinger Band Breakdown | 21 | -11.1% | 33% | July 23, 2026 |
| 200-Day Moving Average TouchActive now | 14 | +3.7% | 64% | August 5, 2026 |
| Any 20-session window (baseline) | -1.4% | 49% |
Computed by MarketWall from daily closing prices since May 18, 2022. Returns are close-to-close and don't include dividends. Past results describe what happened before; they are not a forecast and not investment advice.
About SGHT
Sight Sciences, Inc., an ophthalmic medical device company, focuses on the development and commercialization of surgical and nonsurgical technologies for the treatment of eye prevalent diseases in the United States. The company operates in two segments, Surgical Glaucoma and Dry Eye. It offers OMNI, a surgical system family of products, such as OMNI Ergo for the catheterization and transluminal viscodilation of Schle…
- Sector
- Health Care
- Industry
- Medical/Dental Instruments
- Employees
- 186
- Website
- www.sightsciences.com/
Fundamentals
- 1-day range
- $8.22$8.85
- Market cap
- $385.77M
- P/E (trailing)
- —
- P/E (forward)
- -20.69
- EPS (trailing)
- $-0.56
- Dividend yield
- —
- Beta
- 2.45
- Avg. volume
- 274.9K
How Sight Sciences Inc. Common Stock Makes Money
Where the revenue actually goes — FY2025 annual results
Source: 10-K filed Mar 4, 2026 · via SEC EDGAR / Finnhub
Forecasts
6 analyst ratings
Sight Sciences Inc. Common Stock Competitors
Chosen by industry and closest market cap.
- SGHTSight Sciences Inc. Common Stock$8.28▼ 5.91%Market cap $385.77MP/E —$3.34$9.71
- CARLCarlsmed Inc. Common Stock$13.41▼ 3.87%Market cap $372.43MP/E —$8.5$17.23
- CLPTClearPoint Neuro Inc. Common Stock$9.07▼ 5.91%Market cap $408.45MP/E —$8.27$28.1
- MOBIMobia Medical Inc. Common Stock$8.09▼ 2.65%Market cap $409.63MP/E —$8.16$15.29
- OFIXOrthofix Medical Inc. Common Stock (DE)$9.38▼ 2.19%Market cap $428.47MP/E —$8.5$16.99
- SIShoulder Innovations Inc. Common Stock$18.09▼ 1.52%Market cap $465.16MP/E —$10.92$24.6
- CERSCerus Corporation Common Stock$2.18▼ 3.54%Market cap $467.54MP/E —$1.38$3.47
| Symbol | Market cap | P/E ratio | Price | 1D | 52-week range |
|---|---|---|---|---|---|
| SGHT Sight Sciences Inc. Common Stock | $385.77M | — | $8.28 | ▼ 5.91% | $3.34$9.71 |
| CARL Carlsmed Inc. Common Stock | $372.43M | — | $13.41 | ▼ 3.87% | $8.5$17.23 |
| CLPT ClearPoint Neuro Inc. Common Stock | $408.45M | — | $9.07 | ▼ 5.91% | $8.27$28.1 |
| MOBI Mobia Medical Inc. Common Stock | $409.63M | — | $8.09 | ▼ 2.65% | $8.16$15.29 |
| OFIX Orthofix Medical Inc. Common Stock (DE) | $428.47M | — | $9.38 | ▼ 2.19% | $8.5$16.99 |
| SI Shoulder Innovations Inc. Common Stock | $465.16M | — | $18.09 | ▼ 1.52% | $10.92$24.6 |
| CERS Cerus Corporation Common Stock | $467.54M | — | $2.18 | ▼ 3.54% | $1.38$3.47 |
P/E shows — for peers not currently carrying a live signal of their own.
Latest news
- Why Is Sight Sciences Stock Gaining Thursday?benzinga · 10/15/2026
- Sight Sciences: Signs Of Progress, But Plenty Of Work RemainsSeekingAlpha · 10/9/2026
- Sight Sciences (SGHT) Stock Gets Fair Value Boost After Analyst Target IncreasesYahoo · 10/8/2026
- Sight Sciences to Debut the OMNI Ultra® Surgical System, the Latest Technology Advancement from the Pioneers of Ab Interno Canaloplasty, at the 2026 American Academy of Ophthalmology (AAO) Annual MeetingYahoo · 10/1/2026
- Sight Sciences, Inc. (SGHT) Presents at Morgan Stanley 24th Annual Global Healthcare Conference TranscriptSeekingAlpha · 9/15/2026
Insider Activity
Insider Actions →- Brenton Taylor · October 2, 2026 · Sale3.0K @ $8.85
- Alison Bauerlein · October 2, 2026 · Sale25.3K @ $8.85
- James Rodberg · October 2, 2026 · Sale7.2K @ $8.85
- David Badawi · October 1, 2026 · Sale7.8K @ $9.05
- Paul Badawi · October 1, 2026 · Sale29.7K @ $9.05
- Rashid Kashif · August 10, 2026 · Grant181.8K
- Jeremy B. Hayden · July 6, 2026 · Sale12.7K @ $5.51
- David Badawi · July 6, 2026 · Sale7.4K @ $5.51
- James Rodberg · July 2, 2026 · Sale6.9K @ $5.36
- Alison Bauerlein · July 2, 2026 · Sale24.2K @ $5.36
- Brenton Taylor · July 1, 2026 · Sale2.8K @ $5.42
- Paul Badawi · July 1, 2026 · Sale28.7K @ $5.42
- Staffan Encrantz · June 10, 2026 · Buy14.1K @ $4.88
- Tamara Fountain · June 4, 2026 · Grant28.3K
- Staffan Encrantz · June 4, 2026 · Grant28.3K
Institutional Ownership
March 31, 2026
- Total shares held
- 22.00M
- Total value held
- $79.69M
- Institutional holders
- 108
- Unknown3.59M
- Unknown2.83M
- Unknown2.40M
- Unknown1.68M
- Unknown1.45M
- Unknown970.0K
- Unknown915.4K
- Unknown835.0K
- Unknown770.9K
- Unknown497.5K
See the full, filterable feed with live charts on the MarketWall dashboard.
AI Market Commentary
AI-generatedAll commentary →Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
October 1, 2026
Sight Sciences to Show OMNI Ultra System at 2026 AOO Meeting
Sight Sciences plans to debut its new OMNI Ultra Surgical System at the upcoming American Academy of Ophthalmology Annual Meeting. This event highlights the company's continued focus on advancing ab interno canaloplasty technology. The stock is currently trading near its 52-week high, reflecting strong recent momentum.
Sight Sciences to Show OMNI Ultra System at 2026 AOO Meeting. Sight Sciences plans to debut its new OMNI Ultra Surgical System at the upcoming American Academy of Ophthalmology Annual Meeting. This event highlights the company's continued focus on advancing ab interno canaloplasty technology. The stock is currently trading near its 52-week high, reflecting strong recent momentum.